性能参数

产品名称

Bromelain

规格

100 mg

货号

GOY-Y1996

 含量

>98.00%

CAS

9001-00-7

别名

N/A

化学名

N/A

分子式

N/A

分子量

分子 N/A

溶解度

N/A

储存条件

Store at -20°C

General tips

用途

仅供科研

价格

电询

详细内容

Bromelain (40 mg/kg; intraperitoneal injection; daily; for 7 days; male Sprague-Dawley rats) pretreatment reduces the motor dysfunction in the parkinsonian rat model of parkinson’s disease (PD). 6-OHDA injection resulted in marked motor impairment which is prevented by pretreatment with Bromelain prior to the lesion[1].

[1]. Adu TS, et al. Effects of bromelain on motor responses following intra-medial forebrain bundle 6-OHDA injection in rat model of parkinsonism. Metab Brain Dis. 2019 Jul 22. [2]. Pavan R, et al. Properties and therapeutic application of bromelain: a review. Biotechnol Res Int. 2012;2012:976203.

硫代乙醇酸钠 AR,80.0%  D-3-甲基苯丙氨酸 98%

硫代乙醇酸钠 BR  L-2-甲基苯丙氨酸 97%

硫代乙醇酸钠 98%  三氟甲磺酸钕 98%

松油醇,异构体混合物,CP  三氟甲磺酸镍(II) 96%

硬酯酸乙酯 97%  三氟甲磺酸镨 98%

油酸甲酯 CP，≥60.0% (GC)  三氟甲磺酸钾 98%

Ciprofibrate10mM (in 1mL DMSO) 25mg 100mg 200mg>98.00%Cas No. 52214-84-3C13H14Cl2O3

Ciglitazone1mg 5mg 10mg 50mg>98.00%Cas No. 74772-77-3C18H23NO3S

Colchicoside5 mg 10 mg 25 mg 50 mg>98.00%Cas No. 477-29-2C27H33NO11

Curcumenol1mg 5mg 10mg 25mg>98.00%Cas No. 19431-84-6C15H22O2

CUDA5mg 10mg 25mg 50mg>98.00%Cas No. 479413-68-8C19H36N2O3

CpdA10mg 25mg 50mg 100mg>98.00%Cas No. 14593-25-0C11H14ClNO2.HCl

CP6713051mg 5mg 10mg 20mg>98.00%Cas No. 445295-04-5C23H19FN2O7